1. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. (30th January 2020) Authors: Zouboulis, C.C.; Nogueira da Costa, A.; Makrantonaki, E.; Hou, X.X.; Almansouri, D.; Dudley, J.T.; Edwards, H.; Readhead, B.; Balthasar, O.; Jemec, G.B.E.; Bonitsis, N.G.; Nikolakis, G.; Trebing, D.; Zouboulis, K.C.; Hossini, A.M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 4(2020) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An additional drug repurposing study for hidradenitis suppurativa/acne inversa. (1st April 2021) Authors: Zouboulis, C.C.; Readhead, B.; Dudley, J.T. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An additional drug repurposing study for hidradenitis suppurativa/acne inversa. (29th November 2020) Authors: Zouboulis, C.C.; Readhead, B.; Dudley, J.T. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗